ERIC BRIMHALL: Open Payments
NPI 1134445109 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 25 payments from 13 companies in 2025. Trend: 2023 $1,312 · 2024 $659 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 3 | $66 |
| Medtronic, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $56 |
| Globus Medical, Inc. | 2 | $55 |
| Boston Scientific Corporation | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $31 |
| SCILEX PHARMACEUTICALS INC. | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $27 |
Products named: PROLATE, QULIPTA, INCEPTIV, Symbravo, General - Pain Management, VYEPTI, ZTLido, OMNIA.
Industry payments across NV — which companies pay providers there.
